Clinical Trial Update: A Study Evaluating Safety and Efficacy of C-CAR039 Treatment in NHL Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the safety and efficacy of the CAR-T therapy C-CAR039 in patients with Non-Hodgkin's lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• C-CAR039

Snippet

Sponsor: Shanghai Tongji Hospital, Tongji University School of Medicine | Conditions: Non-Hodgkin's B-cell Lymphoma | Phase 1 | Status: COMPLETED